98 related articles for article (PubMed ID: 3898135)
1. Ongoing phase II & III studies of the USA National Prostatic Cancer Project.
Elder JS; Gibbons RP
Prog Clin Biol Res; 1985; 185A():427-34. PubMed ID: 3898135
[No Abstract] [Full Text] [Related]
2. Cooperative clinical of single and combined agent protocols: adjuvant protocols. National Prostatic Cancer Project Cooperative Clinical Trials.
Gibbons RP
Urology; 1981 Apr; 17(4 Suppl):48-52. PubMed ID: 7010762
[No Abstract] [Full Text] [Related]
3. Chemotherapy: is it effective in treatment of prostatic cancer?
Murphy GP
Urology; 1984 Nov; 24(5 Suppl):41-7. PubMed ID: 6388094
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
Schmidt JD; Scott WW; Gibbons R; Johnson DE; Prout GR; Loening S; Soloway M; deKernion JB; Pontes JE; Slack NH; Murphy GP
Cancer; 1980 Apr; 45(7 Suppl):1937-46. PubMed ID: 6445225
[No Abstract] [Full Text] [Related]
5. [The study landscape for prostate cancer].
Miller K
Urologe A; 2005 Dec; 44(12):1431-4. PubMed ID: 16292461
[TBL] [Abstract][Full Text] [Related]
6. Atrasentan demonstrates survival benefit in hormone-refractory prostate cancer.
Expert Rev Anticancer Ther; 2002 Jun; 2(3):245. PubMed ID: 12113043
[No Abstract] [Full Text] [Related]
7. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
Németh A; Morvay J; Vécsei B
Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
[No Abstract] [Full Text] [Related]
8. Is chemotherapy ready for clinical use in prostatic cancer patients?
Jones WG
Prog Clin Biol Res; 1988; 269():159-76. PubMed ID: 3293058
[No Abstract] [Full Text] [Related]
9. Is it justified to neglect the role of chemotherapy in the treatment of prostatic cancer?
Jasmin C; Ribaud P
Prog Clin Biol Res; 1987; 243B():255-8. PubMed ID: 3309986
[No Abstract] [Full Text] [Related]
10. Chemotherapy of hormone refractory prostatic cancer.
Stoter G; Jones WG
Prog Clin Biol Res; 1988; 260():123-5. PubMed ID: 3129730
[No Abstract] [Full Text] [Related]
11. M-AMSA in disseminated prostatic carcinoma: a phase II study.
Drelichman A; Decker DA; Al-Sarraf M; Dhabuwala CB
Cancer Treat Rep; 1982 Nov; 66(11):1993-4. PubMed ID: 6897206
[No Abstract] [Full Text] [Related]
12. Chemotherapy of hormonally unresponsive prostatic carcinoma.
deKernion JB; Lindner A
Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
[TBL] [Abstract][Full Text] [Related]
13. [Cycloplatam in the treatment of patients with disseminated prostatic cancer].
Matveev BP; Gorbunova VA; Smirnova NB; Zhumagazin ZhD; Bukharkin BV; Orel NF
Urol Nefrol (Mosk); 1996; (3):34-6. PubMed ID: 8928330
[TBL] [Abstract][Full Text] [Related]
14. Cooperative clinical trials in prostate cancer.
Murphy GP; Slack NH
Prog Clin Biol Res; 1981; 75B():341-6. PubMed ID: 7323102
[No Abstract] [Full Text] [Related]
15. Phase II trial of AMSA in prostatic cancer.
Natale RB; Yagofa A; Watson RC
Cancer Treat Rep; 1982 Jan; 66(1):208-9. PubMed ID: 6895482
[No Abstract] [Full Text] [Related]
16. Chemotherapy for advanced prostate cancer: 25 years later.
Logothetis CJ; Millikan R
J Clin Oncol; 2008 May; 26(15):2423-4. PubMed ID: 18487561
[No Abstract] [Full Text] [Related]
17. Apples and oranges. Re: 7.4-year update of the ongoing bicalutamide Early Prostate Cancer (EPC) trial programme.
Sternberg CN
BJU Int; 2006 Mar; 97(3):435-8. PubMed ID: 16469001
[No Abstract] [Full Text] [Related]
18. Radiopharmaceutical and chemotherapy combinations in metastatic castrate-resistant prostate cancer: a new beginning?
Sartor O
J Clin Oncol; 2009 May; 27(15):2417-8. PubMed ID: 19364953
[No Abstract] [Full Text] [Related]
19. Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer.
Kelloff GJ; Coffey DS; Chabner BA; Dicker AP; Guyton KZ; Nisen PD; Soule HR; D'Amico AV
Clin Cancer Res; 2004 Jun; 10(11):3927-33. PubMed ID: 15173102
[No Abstract] [Full Text] [Related]
20. Cytotoxic agents in prostate cancer: an enigma.
Yagoda A
Semin Urol; 1983 Nov; 1(4):311-21. PubMed ID: 6399617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
